chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cl. states 7-8 days after receiving Tdap she started noticing blood blisters in her mouth, blood on tissue when she blew her nose and bruising "all over [her] body." Cl. went to Dr. who performed lab tests, sent client to ER for admission to hospital last night 5/3/12 secondary low platelet count of 3000. Cl. receiving IVIG presently and also to receive corticosteroids.
Patient admitted to hospital on 8/21/21 for pneumonia due to COVID-19 virus. Patient had received 2 Moderna vaccines, on 4/17/21 and 5/21/21.
patient has already received all their scheduled doses, received 3 doses of menquadfi as of today, supposed to have vaxero today instead of menquadfi with no reported adverse event; received 3rd doses of menquadf today, supposed to have vaxero today instead of menquadfi with no reported adverse event; Initial information received on 27-Jul-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 17 years old female patient who had already received all the scheduled doses, received 3rd doses of meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] today, was supposed to have vaxero today instead with no reported adverse event.  The patient's past vaccination(s) included Menquadfi on 04-Jun-2018 (Dose 1) and on 25-Apr-2023 (Dose 2). The patient's past medical history, medical treatment(s) and family history were not provided.  Concomitant medications included hepatitis B vaccine and varicella zoster vaccine live (OKA/MERCK) (Varivax) for Prophylactic vaccination.  On 27-Jul-2023, the patient received 0.5 mL dose 3 of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine, solution for injection (batch number: U7633AB; expiry date: 25-Apr-2025) via intramuscular route in unknown administration site for Immunization instead of vaxero with no reported adverse event (extra dose administered) (wrong product administered) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Received ZOSTAVAX vaccine accidentally (instead of VARIVAX) noted error on 2/21/13. T = 102 degrees & pt lethargic with complaints (R) arm pain per mom on 2/21/13.
Narrative:  75yo male Pt with hx of ----PMH: Code Description F17.210 Moderate cigarette smoker (10-19 cigs/day) (SCT 160604004) M54.5 Low Back Pain (SCT 279039007) Z72.0 Tobacco User (SCT 110483000) I71.4 AAA- Abdominal aortic aneurysm (SCT 233985008) E11.9 Diabetes Mellitus Type 2 (SCT 68496003) I10. HTN - Hypertension (SCT 38341003) F31.32 Bipolar affective disorder, currently depressed, moderate (SCT 191630001) F63.0 Compulsive gambling (SCT 18085000) 564.0 Fissure in Ano (ICD-9-CM 565.0) F10.11 Nondependent alcohol abuse in remission (SCT 191884001) 601.9 Prostatitis (ICD-9-CM 601.9) 110.9 Tinea (ICD-9-CM 110.9) 477.9 Allergic rhinitis (ICD-9-CM 477.9) 427.89 Bradycardia (ICD-9-CM 427.89) 577.0 Pancreatitis (ICD-9-CM 577.0) Pt self-presented to community emergency facility Emergency Notification Intake Date Presenting to the Facility: 1/4/2022 Hospital Name: Address: Phone: Chief complaint: Chest Pain Primary Diagnosis: Patient Admitted? Yes Route of Admission:ER Date/Time of Admission: 1/4/2022 Admitting Diagnosis: Chest Pain Care Provider: Confirm Level of Care: Acute Inpatient Care Pt died at this facility on 1/5/21. Pt had received  covid vaccines on 1/22/21, 2/22/21, & 12/15/22. Not able to assess if this death is related to covid vaccines or not given death occured at outside hospital.  No information in hospital chart notes.
Patient fell forward about 5 minutes after receiveing vaccines.  Patient went down on the floor (fell dizzy).  Patient continued to be checked for an hour; recovered.
This is a spontaneous report obtained from a contactable pharmacist through a Pfizer sales representative. A patient of an unspecified age, gender, race and ethnicity received PREVNAR 13 on an unspecified date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced most irritation out of all vaccines given. Clinical outcome was unknown at time of this report. The information on the lot number has been requested.
Hot flashes; Body aches; Low energy; Chills; Headache; Lymph node swelling on armpit, neck, and elbow; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 13May2021 as a single dose for COVID-19 immunisation. Medical history included no health issues. The patient had no known allergies. The patient received unspecified medication for birth control within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 22Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced chills, hot flashes, headache, body aches, low energy and lymph node swelling on armpit, neck, and elbow at the same side of the shot. It was unknown whether therapeutic measure was taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, hot flashes, headache, body aches, low energy, lymph node swelling on armpit, neck and elbow was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recvd vax;foster mom stated excessive high fever, irritability & extreme soreness at inject site;mom stated "I won't bring him for shots any more"; referred to pvt MD;
unilat raised pruritic rash(looked like sunburn)on lt leg/stomach;saw MD 9JUN93 & tx w/Triamcinolone 01% topical;saw NP 11JUN93;rash look like erythema multiforme w/target lesions on arms,elbows,fingers,legs,stom,non pruritic;no-ongoing inf
death Narrative: Patient received his COVID #1 vaccine on 1/4/2021. He is noted to be a dialysis patient and on 1/21/2021 was given a RX for treatment of a UTI. On 1/24/2021, he was admitted to a facility with a syncopal episode. He remained there until 2/2/2021 when he discharged to home. On 2/4/2021, notes indicate that he passed away in his sleep that night. No autopsy reports available. 31 days from time of vaccine #1 and date of death, does not appear that he received vaccine #2.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a female of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: COPD (chronic obstructive pulmonary disease). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin were not reported, batch number: unknown, expiry: unknown) dose was not reported, 1 total was administered on 01-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date in DEC-2021, the patient got covid even after receiving the primary vaccination (confirmed covid-19 infection and had confirmed clinical vaccination failure). The patient got a positive test from hospital (Laboratory data included: COVID-19 virus test Positive). The patient was in close contact with the positive case of covid (intimate relationship) that hot hospitalized because of his previous condition. The patients COPD was not worse since the infection and she was doing fine. The patient also experienced headache, lost sense of smell, lost sense of taste. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000234344.; Sender's Comments: V0: 20220610230-covid-19 vaccine ad26.cov2.s-confirmed clinical vaccination failure . The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Swollen lymph nodes in both arms; Swollen lymph nodes on both breasts; Swollen lymph nodes on neck; Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), LYMPHADENOPATHY (Swollen lymph nodes in both arms), LYMPHADENOPATHY (Swollen lymph nodes on both breasts) and LYMPHADENOPATHY (Swollen lymph nodes on neck) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes in both arms), LYMPHADENOPATHY (Swollen lymph nodes on both breasts) and LYMPHADENOPATHY (Swollen lymph nodes on neck). On 21-Mar-2021, PAIN IN EXTREMITY (Sore Arm) outcome was unknown. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes in both arms), LYMPHADENOPATHY (Swollen lymph nodes on both breasts) and LYMPHADENOPATHY (Swollen lymph nodes on neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient symptoms onset was on 8/6, she was hospitalize at Hospital in city from 8/10 through 8/16 and diagnosed with COVID pneumonia. She will be in isolation until 8/26. PUI other underlying condition/risk factors lung cancer, melanoma and previously suffered a stroke.
After my second shot at the end of March I started having vague symptoms of tiredness and weakness.  In August I was hospitalized with a hemoglobin level of 2.9.  I was near death.  The hospital doctor said the hemoglobin had to have been dropping for about 6 months.  I have never had any blood disorder, anemia or low hemoglobin prior to the COVID vaccines.  All the tests I had revealed no bleed to explain this fatal hemoglobin level,  I strongly believe it was from the COVID vaccines. My hemoglobin is going up after numerous blood transfusions and daily iron pills but is still not back to normal.  The doctor's I spoke with neither confirmed nor denied my issues were a result of the vaccine but I think it is highly suspicious. I have never had anything like this and after all this testing no reason for this serious drop in hemoglobin was found.
Symptoms (itching, irritation) began 11/11/2019 am in perineal/buttocks area and progressed to small papules, blisters.  Diagnosed with shingles by Dr. at OB/GYN.
flu-like symptoms; general soreness; fever of 101.5; headache; substantial soreness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (general soreness), PYREXIA (fever of 101.5), HEADACHE (headache) and VACCINATION SITE PAIN (substantial soreness at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (general soreness), PYREXIA (fever of 101.5), HEADACHE (headache) and VACCINATION SITE PAIN (substantial soreness at the injection site). On 26-Jan-2021, PYREXIA (fever of 101.5) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (general soreness), HEADACHE (headache) and VACCINATION SITE PAIN (substantial soreness at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 101.5 (High) Fever.         Treatment information was not provided. Concomitant medications were not reported.
Diarrhea, chills, dry heaves. Went to hospital was admitted stayed 5 days.
Headache, Myalgia, Arthralgia, HA, fatigue, body aches and severe pain Narrative:
Bilateral new onset tinnitus started about 1 week following dose 1.  It has continued, with slight improvement after 4 weeks. No treatment has been attempted.
toothache; This is a spontaneous report from a contactable consumer (patient)  A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation . The patient medical history and concomitant medications were not reported. Patient got the first of the vaccine shot and was scheduled for the second shot on 20Mar2021. On 16Mar2021, patient had a toothache and he took 1 pill of amoxicillin for his toothache. His daughter told him that he could not take the vaccine now that he was taking amoxicillin. Caller wanted to know if that was true.The outcome of the event toothache was unknown.No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
pain in the arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 2 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix approximately 2 months ago and had pain in the arm he received his vaccine.  The reporter stated that pain just started (the day of reporting). The reporter did not consent to follow up. No additional details were at the time of reporting. The reporter might call back.
poster online that claimed "Merck admitted that a person who got ZOSTAVAX transmitted chicken pox to a child.; poster online that claimed "Merck admitted that a person who got ZOSTAVAX transmitted chicken pox to a child.; This spontaneous report as received from a consumer concerning a child patient of unknown age, race and gender.  The patient's pertinent medical history, concurrent conditions, drug allergies or reactions, historical and concomitant drugs were not reported.  It was reported that the consumer saw a poster online that claimed "MERCK admitted that a person who got Zoster Vaccine Live (ZOSTAVAX) transmitted chicken pox to a child (secondary transmission).   At the reporting time, the outcome of the events was not reported.  The causal relationship between Zoster Vaccine Live (ZOSTAVAX) and the events was reported as related.
Patient given TDAP March 30, 2015 here today. 4/6/16 states had bad reaction pap, redness, purple bruising and lumps under arm. Here today no ss as described.
2-3 days after vaccine given Patient reported severe rash, pain, swelling R lower leg. Also says nausea, fatigue, vomiting, body aches for 2 weeks aftergiven.
Received shot around 4pm. First 10 minutes, then arm started throbbing. started getting dizzy and fatigue. Had weakness and abdominal pain, sweating profusely. Couldn't cool down. Felt winded, severe abdominal pain 10-15 minutes. Still having pain at the injection site. started having chills and then started to fell better.
Muscle weakness, extreme pain in joints, legs, feet, ankles, arms, shoulders, elbows, fingers, lower back and hips. Also, Erythema nodosum rash
Take evaluation Day 7 (7/7/03): 10mm pustule, mininal erythema.  Adverse Event Active Surveillance interview Day 29 (7/29/03): Pt reports on Day 9 (7/9/03) left deltoid area became swollen, sore and inflamed beyond the size of the Op-Site (9.5cm X 8.5 cm).  The underarm/axilla along bicep was sore with palpable lymph nodes.  Afebrile.  Pt reports slow and spontaneous recovery over period of 5-7 days.
2 weeks after received vaccine started with blister at vaccine site. On day of eval had red papules on anterior thigh some with vesicular appearance.
rash under both arms; not really tired, just tired; Diarrhea; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for two patients. This is the first of two reports. A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVD-19 VACCINE; Batch/Lot Number: EN6203), via an unspecified route of administration, administered in left arm on 26Feb2021 (at the age of 72-year-old) as dose 2, single for COVID-19 immunization. The patient did not have any medical history. There were no concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVD-19 VACCINE; Batch/Lot Number: EN9581), via an unspecified route of administration, administered in left arm on 03Feb2021 at 12:30 (at the age of 72-year-old) as dose 1, single for COVID-19 immunization and did not have any adverse event. On 26Feb2021, the patient was not really tired, just tired, that started right after got the shot, that she was yawning and yawning and tired and was fine the next day, states she had diarrhea that has lasted 2-3 days and that also started same day as the shot and it was ongoing, but just about gone. On 28Feb2021, the patient had rash under both arms, that started 2 days after the second shot and has remained the same, has not gone anywhere and she has been putting anti itch cream and Neosporin on the rash. Caller stated that she did not take anything for the diarrhea. Caller clarified that these symptoms all happened after the 2nd COVID 19 vaccine that she received 26Feb2021. The outcome was recovered for not really tired, just tired on 27Feb2021 and recovering for diarrhoea whereas the event outcome was not recovered for rash under both arms.  No follow-up attempts are possible; no further information is expected.  ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021257924 same reporter/diff patient
Her right knee felt swollen and painful and like it had been twisted. This started the evening the vaccine was given(11/21)(given in the AM). The next night (11/22) after the vaccine her right hand became visibly swollen and too painful to move. Both issues are improving and she states they are resolving without medical care.
First shot: Fever (100.6), diarrhea, vomit, fatigue; First shot: Fever (100.6), diarrhea, vomit, fatigue; First shot: Fever (100.6), diarrhea, vomit, fatigue; First shot: Fever (100.6), diarrhea, vomit, fatigue; This is a spontaneous report from a contactable consumer. A 41-year-old female patient (non-pregnant) received BNT162B2 (BNT162B2, solution for injection, Batch/Lot Number: ER8731 and expiration date: not reported), via an unspecified route of administration, administered in Arm Right on 10Apr2021 16:00 as a dose 1 single (age at vaccination: 41-year-old)for covid-19 immunisation. Medical history included no known allergies: No other medical history. The patient's concomitant medications were not reported. The patient is not pregnant at time of vaccination. The patient experienced first shot: fever (100.6), diarrhea, vomit, fatigue on 11Apr2021 16:00. The patient underwent lab tests and procedures which included body temperature: 100.6 on Fever (100.6). Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive other medications in two weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. no treatment was received for events. Events were reported as non- serious. The patient recovered from all the events.   No follow-up attempts are possible. No further information is expected.
Following a second dose of the ENGERIX Hepatitis B Vaccine, I experienced a mildly painful (but noticeable) pinching on my right lower leg muscles. This happened with the first dose as well, but the pain from the first dose lasted only an hour max, and this pain keep coming and going.
Headache, dizziness, vomiting over 3x in a 7 hour time period, pressure in neck up to the back of head, tightness in the back of head, faint feeling.
Dizzy ("Lightheaded"); sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and DIZZINESS (Dizzy ("Lightheaded")) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Feb-2021, the patient experienced DIZZINESS (Dizzy ("Lightheaded")). At the time of the report, PAIN IN EXTREMITY (sore arm) and DIZZINESS (Dizzy ("Lightheaded")) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.